Elanco Animal Health is making progress on debt repayment, new product approvals, and launches. Learn why ELAN stock is a Buy ...
The rumoured sale of Bayer’s animal health unit to Elanco has been confirmed as going ahead, with the German company set to make $7.6 billion from the sale. The divestment will make Elanco the ...
Bayer has delayed a planned sale of its animal health unit to private equity interests in order to explore a merger with US firm Elanco, claims Reuters. Citing three separate anonymous sources ...